Browse our anti-Immunoglobulin kappa Variable 1-27 (IGKV1-27) Antibodies

On are 6 Immunoglobulin kappa Variable 1-27 (IGKV1-27) Antibodies from 5 different suppliers available. A total of 8 Immunoglobulin kappa Variable 1-27 products are currently listed.
list all antibodies Gene Name GeneID UniProt
IGKV1-27 7128 P21580

Most Popular Reactivities for anti-Immunoglobulin kappa Variable 1-27 (IGKV1-27) Antibodies

anti-Human Antibodies:

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-Immunoglobulin kappa Variable 1-27 Antibodies

Go to our pre-filtered search.

More Antibodies against Immunoglobulin kappa Variable 1-27 Interaction Partners

Human Immunoglobulin kappa Variable 1-27 (IGKV1-27) interaction partners

  1. TNFAIP3 (show TNFAIP3 Antibodies) rs10499194 T allele and CT genotype were associated with an increased risk for AIH-1 (show AMELX Antibodies)

  2. Haploinsufficiency of TNFAIP3 (A20 (show TNFAIP3 Antibodies)) by a germline heterozygous mutation leads to the autoimmune lymphoproliferative syndrome (ALPS) phenotype.

  3. These results suggested that A20 (show TNFAIP3 Antibodies) is involved in regulating intracerebral hemorrhage-induced inflammatory injury in both the central and peripheral system

  4. In targeted sequencing, a disruptive mutation of TNFAIP3 (show TNFAIP3 Antibodies) was the most common alteration (54%), followed by mutations of TBL1XR1 (show TBL1XR1 Antibodies) (18%) and cAMP response element binding proteins (CREBBP (show CREBBP Antibodies)) (17%).

  5. the DNA fragment containing the associated SNPs interacts through chromatin looping not only with TNFAIP3 (show TNFAIP3 Antibodies), but also with IL20RA (show IL20RA Antibodies), located 680 kb upstream.

  6. The findings suggest that TNFAIP3 (show TNFAIP3 Antibodies) protein may be an independent prognostic marker for poor survival, and a promising target for esophageal squamous cell carcinoma therapy.

  7. Study demonstrates that the rs7749323 in the TNFAIP3 (show TNFAIP3 Antibodies) gene is strongly associated with the late onset myasthenia gravis(with positive AChR Ab but without thymoma).

  8. Influenza a virus NS1 (show PTPN11 Antibodies) has a role in inducing A20 (show TNFAIP3 Antibodies) contributes to viral replication by suppressing interferon (show IFNA Antibodies)-induced antiviral response

  9. Inductive regulation of A20 (show TNFAIP3 Antibodies) by glucocorticoid receptor (show NR3C1 Antibodies) and NF-kappaB (show NFKB1 Antibodies) contributes to cytokine repression in human airway smooth muscle.

  10. Our study confirms the involvement of the TNFAIP3 (show TNFAIP3 Antibodies) tumor suppressor gene in classic Hodgkin lymphoma.

Immunoglobulin kappa Variable 1-27 (IGKV1-27) Antigen Profile

Antigen Summary

This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and ubiqitin-editing enzyme, and has been shown to inhibit NF-kappa B activation as well as TNF-mediated apoptosis. The encoded protein, which has both ubiquitin ligase and deubiquitinase activities, is involved in the cytokine-mediated immune and inflammatory responses. Several transcript variants encoding the same protein have been found for this gene.

Alternative names and synonyms associated with Immunoglobulin kappa Variable 1-27 (IGKV1-27)

  • tumor necrosis factor, alpha-induced protein 3 (TNFAIP3) antibody
  • A20 antibody
  • OTUD7C antibody
  • TNFA1P2 antibody

Protein level used designations for IGKV1-27

OTU domain-containing protein 7C , TNF alpha-induced protein 3 , putative DNA-binding protein A20 , tumor necrosis factor alpha-induced protein 3 , tumor necrosis factor inducible protein A20 , zinc finger protein A20

7128 Homo sapiens
Selected quality suppliers for anti-Immunoglobulin kappa Variable 1-27 (IGKV1-27) Antibodies
Did you look for something else?